Literature DB >> 16542347

Effects of rapamycin on number activity and eNOS of endothelial progenitor cells from peripheral blood.

T-G Chen1, J Z Chen, X-X Wang.   

Abstract

The aim of this investigation is to determine whether rapamycin treatment has any effect on endothelial progenitor cells (EPCs). Total mononuclear cells (MNCs) were isolated from peripheral blood by Ficoll density gradient centrifugation, and then the cells were plated on fibronectin-coated culture dishes. After 7 days in culture, attached cells were stimulated with rapamycin (in a series of final concentrations: 0.1, 1.0, 2.0 and 5.0 g/ml) for 6, 12, 24 and 48 h. EPCs were characterized as adherent cells, double positive for DiLDL uptake and lectin binding by direct fluorescence staining. EPC proliferation and migration were determined using the MTT assay and a modified version of the Boyden chamber assay, respectively. An EPC adhesion assay was performed by replating the cells on fibronectin-coated dishes; adherent cells were then counted. Tube formation activity was assayed by using a tube formation assay kit and endothelial nitric oxide synthase (eNOS) was assayed by Western blot analysis. Incubation of isolated human MNCs with rapamycin decreased the number of EPCs present; rapamycin also decreased EPCs proliferative, migratory, adhesive, tube formation capacity and eNOS production in a concentration- and time-dependent manner. Rapamycin was found to decrease the number, proliferative, migratory, adhesive and tube formation capacities of the EPCs, and also was found to decreases eNOS in the EPCs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542347      PMCID: PMC6495845          DOI: 10.1111/j.1365-2184.2006.00375.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  25 in total

1.  Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.

Authors:  M Vasa; S Fichtlscherer; A Aicher; K Adler; C Urbich; H Martin; A M Zeiher; S Dimmeler
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

2.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Authors:  Jonathan M Hill; Gloria Zalos; Julian P J Halcox; William H Schenke; Myron A Waclawiw; Arshed A Quyyumi; Toren Finkel
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

Review 3.  Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.

Authors:  S N Sehgal
Journal:  Clin Biochem       Date:  1998-07       Impact factor: 3.281

4.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Authors:  Markus Guba; Philipp von Breitenbuch; Markus Steinbauer; Gudrun Koehl; Stefanie Flegel; Matthias Hornung; Christiane J Bruns; Carl Zuelke; Stefan Farkas; Matthias Anthuber; Karl-Walter Jauch; Edward K Geissler
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

5.  Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

Authors:  F J Dumont; M J Staruch; S L Koprak; M R Melino; N H Sigal
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

6.  Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice.

Authors:  G C Schatteman; H D Hanlon; C Jiao; S G Dodds; B A Christy
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

7.  Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.

Authors:  A A Kocher; M D Schuster; M J Szabolcs; S Takuma; D Burkhoff; J Wang; S Homma; N M Edwards; S Itescu
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

8.  Neoendothelialization after peripheral blood stem cell transplantation in humans: a case report of a Tokaimura nuclear accident victim.

Authors:  Toru Suzuki; Masamichi Nishida; Satoru Futami; Keiko Fukino; Toshihiro Amaki; Kenichi Aizawa; Shigeru Chiba; Hisamaru Hirai; Kazuhiko Maekawa; Ryozo Nagai
Journal:  Cardiovasc Res       Date:  2003-05-01       Impact factor: 10.787

9.  Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood.

Authors:  J Z Chen; J H Zhu; X X Wang; J H Zhu; X D Xie; J Sun; Y P Shang; X G Guo; H M Dai; S J Hu
Journal:  J Mol Cell Cardiol       Date:  2004-02       Impact factor: 5.000

10.  VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells.

Authors:  Petri Salven; Satu Mustjoki; Riitta Alitalo; Kari Alitalo; Shahin Rafii
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

View more
  22 in total

1.  Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating endothelial nitric oxide synthase expression.

Authors:  Kan Wang; Xiaosheng Hu; Changqing Du; Shike Tu; Furong Zhang; Xudong Xie
Journal:  Mol Cell Biochem       Date:  2012-03-29       Impact factor: 3.396

2.  Small molecules affect human dental pulp stem cell properties via multiple signaling pathways.

Authors:  Mey Al-Habib; Zongdong Yu; George T-J Huang
Journal:  Stem Cells Dev       Date:  2013-05-24       Impact factor: 3.272

3.  Effects of tumour necrosis factor-alpha on activity and nitric oxide synthase of endothelial progenitor cells from peripheral blood.

Authors:  T-G Chen; Z-Y Zhong; G-F Sun; Y-X Zhou; Y Zhao
Journal:  Cell Prolif       Date:  2011-08       Impact factor: 6.831

4.  Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.

Authors:  Hai-Tao Liu; Fei Li; Wen-Yong Wang; Xiao-Jing Li; Yi-Meng Liu; Rui-An Wang; Wen-Yi Guo; Hai-Chang Wang
Journal:  Tex Heart Inst J       Date:  2010

5.  [Primary headaches and the influence of inflammatory diseases of the CNS and their respective immunmodulatory therapy].

Authors:  M Empl; A Straube
Journal:  Schmerz       Date:  2007-10       Impact factor: 1.107

6.  Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage.

Authors:  Ji Chen; Shuzhen Chen; Yusen Chen; Cheng Zhang; Jinju Wang; Wenfeng Zhang; Gang Liu; Bin Zhao; Yanfang Chen
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-04-19       Impact factor: 4.310

7.  Preclinical evaluation of a novel abluminal surface coated sirolimus eluting stent with biodegradable polymer matrix.

Authors:  Prakash Sojitra; Manish Doshi; Marco Galloni; Christina Vignolini; Ashwin Vyas; Bhavesh Chevli; Imad Sheiban
Journal:  Cardiovasc Diagn Ther       Date:  2015-08

8.  NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro.

Authors:  Jiali Zhang; Bin Peng
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

9.  Adiponectin levels are associated with the number and activity of circulating endothelial progenitor cells in patients with coronary artery disease.

Authors:  Zhi-qiang Ying; Dan-dan Zhong; Geng Xu; Miao-yan Chen; Qing-yu Chen
Journal:  J Zhejiang Univ Sci B       Date:  2009-05       Impact factor: 3.066

10.  Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis.

Authors:  Sheng-Zhang Lin; Wei-Tian Wei; Hui Chen; Kang-Jie Chen; Hong-Fei Tong; Zhao-Hong Wang; Zhong-Lin Ni; Hai-Bin Liu; Hong-Chun Guo; Dian-Lei Liu
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.